By Dr. Anish Shah Bronx Lebanon Hospital On August 11, 2023, the U.S. Food and Drug Administration granted regular approval to niraparib and abiraterone acetate (Akeega) plus prednisone for adult patients
Presented by: Ulka Vaishampayan, M.D., Professor of Medicine/GU Oncology at University of Michigan School of Medicine, Ann Arbor, MI. Covered by: Abdul Moiz Khan, M.D, Chief Fellow of Hematology and Oncology at
MoreBy Dr. Anish Shah Bronx Lebanon Hospital On August 11, 2023, the U.S. Food and Drug Administration granted regular approval to niraparib and abiraterone acetate (Akeega) plus prednisone for adult patients
More